Clinical Trial Update: An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacology of VR942 in healthy volunteers and patients with mild asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• VR942

Snippet

Sponsor: Vectura Limited | Conditions: Asthma | Phase 1 | Status: COMPLETED